To keep pace with medicine's unpredictable changes, medical trainees must learn to accurately monitor and evaluate themselves via metacognition (i.e., thinking about thinking). The Metacognitive Awareness Inventory (MAI) can assess and guide the metacognitive development of trainees. This study summarizes existing psychometric evidence and meta‐analyzes the internal consistency of the MAI across studies involving health professions education. In 2023, a literature search was performed across six databases for records that met predefined inclusion criteria. After two rounds of screening, MAI validity and reliability data were extracted from the eligible studies for analysis. Validity evidence for the dichotomous, five‐point Likert, and sliding analog versions of the MAI were rated and analyzed according to “test content,” “response processes,” “internal structure,” “relations to other variables,” and “consequences of testing.” The internal consistency range (min‐max) of the MAI was estimated using random‐effects, restricted maximum likelihood (REML) meta‐analysis. Among the 1966 records screened, 23 studies met the inclusion criteria. The five‐point Likert version of the MAI was the most supported, with validity evidence in the “test content,” “internal structure,” and “relations to other variables” categories. None of the MAI versions presented evidence related to “response processes” or “consequences of testing.” The lowest aggregated internal consistency was estimated to be 0.805 and the highest as 0.844, suggesting very good reliability. The five‐point Likert scale version of the MAI is most supported for use in health professions education, though validation efforts should continue to address all five sources of validity.
Traumatic brain injury (TBI) has been discussed as a risk factor for Alzheimer’s disease (AD) due to its association with dementia risk and earlier cognitive symptom onset. However, the mechanisms behind this relationship are unclear. Some studies have suggested TBI may increase pathological protein deposition in an AD-like pattern; others have failed to find such associations. This review covers literature that uses positron emission tomography (PET) of amyloid-β and/or tau to examine subjects with history of TBI who are at risk for AD due to advanced age. A comprehensive literature search was conducted on January 9, 2023, and 24 resulting citations met inclusion criteria. Common methodological concerns included small samples, limited clinical detail about subjects’ TBI, recall bias due to reliance on self-reported TBI, and an inability to establish causation. For both amyloid and tau, results were widespread but inconsistent. The regions which showed the most compelling evidence for increased amyloid deposition were the cingulate gyrus, cuneus/precuneus, and parietal lobe. Evidence for increased tau was strongest in the medial temporal lobe, entorhinal cortex, precuneus, and frontal, temporal, parietal, and occipital lobes. However, conflicting findings across most regions of interest in both amyloid- and tau-PET studies indicate the critical need for future work in expanded samples and with greater clinical detail to offer a clearer picture of the relationship between TBI and protein deposition in older subjects at risk for AD.